Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity

Inclusion Criteria:

- Male or female, age greater than or equal to 18 years at the time of signing informed
consent

- Body Mass Index (BMI) greater than or equal to 27 kg/m^2 '

- History of at least one self-reported unsuccessful dietary effort to lose body weight

- Diagnosed with type 2 diabetes (haemoglobin A1c 7-10% (53-86 mmol/mol) (both
inclusive)) 180 days or longer prior to the day of screening

Exclusion Criteria:

- A self-reported change in body weight greater than 5 kg (11 lbs) within 90 days before
screening irrespective of medical records

- Renal impairment measured as estimated Glomerular Filtration Rate (eGFR) value of less
than 30 mL/min/1.73 m^2 (less than 60 ml/min/1.73 m^2 in subjects treated with
Sodium-glucose Cotransporter 2 Inhibitors) according to chronic kidney disease
(CKD)-Epidemiology Collaboration (EPI) creatinine equation as defined by Kidney
Disease: Improving Global Outcomes (KDIGO) 2012 by the central laboratory at screening

- Uncontrolled and potentially unstable diabetic retinopathy or maculopathy. Verified by
a pharmacologically pupil-dilated fundus examination performed by an ophthalmologist
or an equally qualified health care provider (e.g. optometrist) within the past 90
days prior to screening or in the period between screening and randomisation